Kidney failure outcomes in children and young adults with sickle cell disease in the United States Renal Data System

被引:5
作者
Zahr, Rima S. [1 ]
Ataga, Kenneth I. [2 ]
Lebensburger, Jeffrey D. [3 ]
Winer, Jeffrey C. [4 ]
机构
[1] Univ Tennessee, Div Pediat Nephrol & Hypertens, Hlth Sci Ctr, Memphis, TN 38163 USA
[2] Univ Tennessee, Hlth Sci Ctr, Ctr Sickle Cell Dis, Memphis, TN USA
[3] Univ Alabama Birmingham, Div Pediat Hematol & Oncol, Birmingham, AL USA
[4] Univ Tennessee, Div Acad Hosp Med, Dept Pediat, Hlth Sci Ctr, Memphis, TN USA
关键词
Transplant; Dialysis; Sickle cell disease; Outcomes; ALBUMINURIA; MORTALITY;
D O I
10.1007/s00467-023-06136-0
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Children and young adults with sickle cell disease (SCD) develop kidney disease early in childhood, with some patients progressing to require dialysis and kidney transplantation. The prevalence and outcomes of children with kidney failure (chronic kidney disease stage 5) due to SCD are not well described. This study aimed to assess the outcome of children and young adults with SCD with kidney failure compared to matched children and young adults without SCD with kidney failure in a large national database. Methods Utilizing the United States Renal Data System (USRDS), we retrospectively examined kidney failure outcomes in children and young adults with SCD from 1998 to 2019. Results We identified 97 patients with SCD who developed kidney failure and identified 96 matched controls with a median age of 19 years (IQR 17, 21) at the time of kidney failure diagnosis. SCD patients had significantly shorter survival (8.4 years vs. 14.0 years, p < 0.001) and had a longer waiting time for their first transplant when compared to matched non-SCD kidney failure patients (12.1 years vs. 7.3 years, p < 0.001). Conclusions Children and young adults with SCD kidney failure have significantly higher mortality when matched to nonSCD kidney failure children and experience a longer mean time to kidney transplant.
引用
收藏
页码:619 / 623
页数:5
相关论文
共 15 条
  • [1] Mortality and Access to Kidney Transplantation in Patients with Sickle Cell Disease-Associated Kidney Failure
    Bae, Sunjae
    Johnson, Morgan
    Massie, Allan B.
    Luo, Xun
    Haywood, Carlton, Jr.
    Lanzkron, Sophie M.
    Grams, Morgan E.
    Segev, Dorry L.
    Purnell, Tanjala S.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (03): : 407 - 414
  • [2] Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease
    Bartolucci, Pablo
    Habibi, Anoosha
    Stehle, Thomas
    Di Liberto, Gaetana
    Rakotoson, Marie Georgine
    Gellen-Dautremer, Justine
    Loric, Sylvain
    Moutereau, Stephane
    Sahali, Dil
    Wagner-Ballon, Orianne
    Remy, Philippe
    Lang, Philippe
    Grimbert, Philippe
    Audureau, Etienne
    Godeau, Bertrand
    Galacteros, Frederic
    Audard, Vincent
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (06): : 1847 - 1853
  • [3] Transplantation Mediates Much of the Racial Disparity in Survival from Childhood-Onset Kidney Failure
    Becerra, Adan Z.
    Chan, Kevin E.
    Eggers, Paul W.
    Norton, Jenna
    Kimmel, Paul L.
    Schulman, Ivonne H.
    Mendley, Susan R.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (07): : 1265 - 1275
  • [4] Advances in the diagnosis and treatment of sickle cell disease
    Brandow, A. M.
    Liem, R. I.
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [5] mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization
    Gan, Boyi
    Sahin, Erguen
    Jiang, Shan
    Sanchez-Aguilera, Abel
    Scott, Kenneth L.
    Chin, Lynda
    Williams, David A.
    Kwiatkowski, David J.
    DePinho, Ronald A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (49) : 19384 - 19389
  • [6] Improved Fetal Hemoglobin With mTOR Inhibitor-Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease
    Gaudre, N.
    Cougoul, P.
    Bartolucci, P.
    Dorr, G.
    Bura-Riviere, A.
    Kamar, N.
    Del Bello, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (08) : 2212 - 2214
  • [7] Mortality Rates and Age at Death from Sickle Cell Disease: US, 1979-2005
    Lanzkron, Sophie
    Carroll, C. Patrick
    Haywood, Carlton, Jr.
    [J]. PUBLIC HEALTH REPORTS, 2013, 128 (02) : 110 - 116
  • [8] Outcomes of Kidney Transplant Recipients with Sickle Cell Disease: An Analysis of the 2000-2019 UNOS/OPTN Database
    Leeaphorn, Napat
    Thongprayoon, Charat
    Vaitla, Pradeep
    Hansrivijit, Panupong
    Jadlowiec, Caroline C.
    Mao, Shennen A.
    Chewcharat, Api
    Katari, Sreelatha
    Pattharanitima, Pattharawin
    Boonpheng, Boonphiphop
    Kaewput, Wisit
    Mao, Michael A.
    Cooper, Matthew
    Cheungpasitporn, Wisit
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [9] American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
    Liem, Robert, I
    Lanzkron, Sophie
    Coates, Thomas D.
    DeCastro, Laura
    Desai, Ankit A.
    Ataga, Kenneth, I
    Cohen, Robyn T.
    Haynes, Johnson, Jr.
    Osunkwo, Ifeyinwa
    Lebensburger, Jeffrey D.
    Lash, James P.
    Wun, Theodore
    Verhovsek, Madeleine
    Ontala, Elodie
    Blaylark, Rae
    Alahdab, Fares
    Katabi, Abdulrahman
    Mustafa, Reem A.
    [J]. BLOOD ADVANCES, 2019, 3 (23) : 3867 - 3897
  • [10] High one year mortality in adults with sickle cell disease and end-stage renal disease
    McClellan, Ann C.
    Luthi, Jean-Christophe
    Lynch, Janet R.
    Soucie, J. Michael
    Kulkarni, Roshni
    Guasch, Antonio
    Huff, Edwin D.
    Gilbertson, David
    McClellan, William M.
    DeBaun, Michael R.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (03) : 360 - 367